These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34769108)

  • 1. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.
    Kłos P; Dabravolski SA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Control in Inflammatory Gastrointestinal Diseases.
    Sui GY; Wang F; Lee J; Roh YS
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
    Kim ER; Chang DK
    World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
    Goel GA; Kandiel A; Achkar JP; Lashner B
    Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
    Du L; Kim JJ; Shen J; Chen B; Dai N
    Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli.
    Khan AA; Khan Z; Malik A; Kalam MA; Cash P; Ashraf MT; Alshamsan A
    Life Sci; 2017 Jul; 180():60-67. PubMed ID: 28506682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer.
    Liang L; Lin R; Xie Y; Lin H; Shao F; Rui W; Chen H
    Int J Biol Sci; 2021; 17(10):2548-2560. PubMed ID: 34326693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
    Frigerio S; Lartey DA; D'Haens GR; Grootjans J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
    Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
    Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies.
    Cassotta M; Cianciosi D; De Giuseppe R; Navarro-Hortal MD; Armas Diaz Y; Forbes-Hernández TY; Pifarre KT; Pascual Barrera AE; Grosso G; Xiao J; Battino M; Giampieri F
    Nutrition; 2023 Jun; 110():111980. PubMed ID: 36965240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer in patients with inflammatory bowel disease.
    Vagefi PA; Longo WE
    Clin Colorectal Cancer; 2005 Jan; 4(5):313-9. PubMed ID: 15663834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Inflammation in the Development of Colorectal Cancer.
    Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
    Samadder NJ; Mukherjee B; Huang SC; Ahn J; Rennert HS; Greenson JK; Rennert G; Gruber SB
    Cancer; 2011 Apr; 117(8):1640-8. PubMed ID: 21472711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
    Yashiro M
    Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
    Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
    Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.